Thrombolytic therapy for submassive/intermediate risk Pulmonary Embolism Evidence and suggestions after PEITHO trial

被引：1
作者：
Marin V., Arnaldo [1 ]
Tomas Gazmuri B., Jose [2 ]
Andresen V., Max [4 ]
Andresen, Max [3 ]
机构：
[1] Univ Chile, Fac Med, Hosp Clin Univ Chile, Med Interna, Santiago 7, Chile
[2] Univ Los Andes, Fac Med, Med Interna, Santiago, Chile
[3] Pontificia Univ Catolica Chile, Fac Med, Dept Med Intens, Santiago, Chile
[4] Pontificia Univ Catolica Chile, Fac Med, Interno Med, Santiago, Chile
来源：
REVISTA MEDICA DE CHILE | 2015年 / 143卷 / 07期
关键词：
Pulmonary embolism; Shock; Thrombectomy; Thrombolytic therapy; RIGHT-VENTRICULAR DYSFUNCTION; TISSUE PLASMINOGEN-ACTIVATOR; MULTICENTER DOUBLE-BLIND; INTRACRANIAL HEMORRHAGE; PROGNOSTIC VALUE; MANAGEMENT; ALTEPLASE; OUTCOMES; HEPARIN; TENECTEPLASE;
D O I：
10.4067/S0034-98872015000700011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Therapy for submassive pulmonary embolism (intermediate risk), remains controversial. New evidence has appeared that may help us in the process of decision making. We review the relevant literature, outline prognostic factors, and discuss current recommendations and controversies regarding the available alternatives such as systemic and catheter-directed thrombolytic use.
引用
收藏
页码：895 / 904
页数：10
相关论文
共 50 条
  • [31] Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism
    Konstantinides, Stavros V.
    Vicaut, Eric
    Danays, Thierry
    Becattini, Cecilia
    Bertoletti, Laurent
    Beyer-Westendorf, Jan
    Bouvaist, Helene
    Couturaud, Francis
    Dellas, Claudia
    Duerschmied, Daniel
    Empen, Klaus
    Ferrari, Emile
    Galie, Nazzareno
    Jimenez, David
    Kostrubiec, Maciej
    Kozak, Matija
    Kupatt, Christian
    Lang, Irene M.
    Lankeit, Mareike
    Meneveau, Nicolas
    Palazzini, Massimiliano
    Pruszczyk, Piotr
    Rugolotto, Matteo
    Salvi, Aldo
    Sanchez, Olivier
    Schellong, Sebastian
    Sobkowicz, Bozena
    Meyer, Guy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (12) : 1536 - 1544
  • [32] Incomplete echocardiographic recovery at 6months predicts long-term sequelae after intermediate-risk pulmonary embolism. A post-hoc analysis of the Pulmonary Embolism Thrombolysis (PEITHO) trial
    Barco, Stefano
    Russo, Mariaconcetta
    Vicaut, Eric
    Becattini, Cecilia
    Bertoletti, Laurent
    Beyer-Westendorf, Jan
    Bouvaist, Helene
    Couturaud, Francis
    Danays, Thierry
    Dellas, Claudia
    Duerschmied, Daniel
    Empen, Klaus
    Ferrari, Emile
    Galie, Nazzareno
    Jimenez, David
    Klok, Frederikus A.
    Kostrubiec, Maciej
    Kozak, Matija
    Kupatt, Christian
    Lang, Irene M.
    Lankeit, Mareike
    Meneveau, Nicolas
    Palazzini, Massimiliano
    Pruszczyk, Piotr
    Rugolotto, Matteo
    Salvi, Aldo
    Sanchez, Olivier
    Schellong, Sebastian
    Sobkowicz, Bozena
    Meyer, Guy
    Konstantinides, Stavros V.
    CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (07) : 772 - 778
  • [33] Anticoagulant Impact on Clinical Outcomes of Pulmonary Embolism Compared With Thrombolytic Therapy; Meta-Analysis
    Su, Yang
    Zou, Dongmei
    Liu, Yi
    Wen, Chaoqun
    Zhang, Xialing
    CLINICAL CARDIOLOGY, 2024, 47 (09)
  • [34] Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem
    Daley, Mitchell J.
    Murthy, Manasa S.
    Peterson, Evan J.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2015, 6 (02) : 57 - 66
  • [35] Thrombolytic therapy for pulmonary embolism
    Hao, Qiukui
    Dong, Bi Rong
    Yue, Jirong
    Wu, Taixiang
    Liu, Guan J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (12):
  • [36] Thrombolytic therapy for pulmonary embolism
    Dong, Bi Rong
    Hao, Qiukui
    Yue, Jirong
    Wu, Taixiang
    Liu, Guan Jian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03):
  • [37] Thrombolytic therapy for pulmonary embolism
    Zuo, Z.
    Yue, J.
    Dong, B. R.
    Wu, T.
    Liu, G. J.
    Hao, Q.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (04):
  • [38] Thrombolytic therapy of pulmonary embolism - A comprehensive review of current evidence
    Arcasoy, SM
    Kreit, JW
    CHEST, 1999, 115 (06) : 1695 - 1707
  • [39] Best evidence in critical care medicineTreatment of submassive pulmonary embolism
    Robert C. McDermid
    Canadian Journal of Anesthesia, 2004, 51 : 846 - 847
  • [40] Systemic Thrombolytic Therapy for Acute Pulmonary Embolism: Who Is a Candidate?
    Konstantinides, Stavros V.
    Barco, Stefano
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (01) : 56 - 65
12345